Evidence map›Paper›PMID 30671276›Full record

ArticleCase reports in urology2018

Multiple and Bilateral Sporadic Renal Cell Carcinomas: A Surgical Challenge.

Antonios Katsimantas, Spyridon Paparidis, Konstantinos Bouropoulos, Nikolaos Ferakis

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in urology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 73% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Antonios KatsimantasDepartment of Urology, Korgialenio-Benakio Hellenic Red Cross Hospital, Athanasaki 1, 11526 Athens, Greece.ORCID 0000-0003-4695-7724
Spyridon PaparidisDepartment of Urology, Korgialenio-Benakio Hellenic Red Cross Hospital, Athanasaki 1, 11526 Athens, Greece.ORCID 0000-0002-5180-7037
Konstantinos BouropoulosDepartment of Urology, Korgialenio-Benakio Hellenic Red Cross Hospital, Athanasaki 1, 11526 Athens, Greece.
Nikolaos FerakisDepartment of Urology, Korgialenio-Benakio Hellenic Red Cross Hospital, Athanasaki 1, 11526 Athens, Greece.ORCID 0000-0002-5730-7308
Hellenic Red Cross · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sporadic, synchronous, bilateral, or unilateral Renal Cell Carcinomas constitute a rare clinical entity. We report the case of a 68-year-old male patient who presented in our department due to incidentally discovered multiple, bilateral renal tumors. Magnetic Resonance Imaging demonstrated cT1b renal tumors at the lower pole of each kidney and a cT1a renal tumor at the upper pole of the right kidney. The patient underwent transperitoneal, laparoscopic left partial nephrectomy with renal artery occlusion, histology revealed high-grade, pT1b, clear-cell renal cell carcinoma; however we observed decline of patient's estimated glomerular filtration rate postoperatively. Forty days postoperatively, he underwent open partial nephrectomy for the right sided tumors with manual compression of the renal parenchyma and no use of ischemia. Histology revealed high-grade, pT1a, clear-cell renal cell carcinoma at the upper pole of the right kidney and low-grade, pT1b, clear-cell renal cell carcinoma at the lower pole of the right kidney. There was no additional decline in the serum creatinine value postoperatively. The patient avoided permanent or temporary dialysis and 6 months postoperatively he demonstrated no recurrence on imaging and his renal function remained stable.

Identifiers

PMID30671276
PMCPMC6317102
OpenAlexW2906427646

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.